SmPC - Ramipril 2.5mg Tablets: Change history
View Summary of Product Characteristics (SmPC - Ramipril 2.5mg Tablets)
Last updated on this site: 21 Oct 2022
Single Variation
Variation Type: IB C.I.2.a
Variation Description:
To register an update to sections 4.3, 4.4, 4.5, 4.6, 4.8 and 5.1 of the SPC in line with the reference product (Tritace 5mg Tablets; PL 04425/0358). Consequentially, the leaflet has been updated.
Addition of ‘sodium-free’ statement in SPC section 4.4 and PIL.
Update to product descriptions in PIL section 6.
SmPC sections updated – 4.3, 4.4, 4.5, 4.6, 4.8, 5.1 and 10
PIL sections updated – Heading, 2, 3, 4, 5 and 6
Last updated on this site: 21 Oct 2022
Single Variation
Variation Type: IB C.I.2.a
Variation Description:
To register an update to sections 4.3, 4.4, 4.5, 4.6, 4.8 and 5.1 of the SPC in line with the reference product (Tritace 5mg Tablets; PL 04425/0358). Consequentially, the leaflet has been updated.
Addition of ‘sodium-free’ statement in SPC section 4.4 and PIL.
Update to product descriptions in PIL section 6.
SmPC sections updated – 4.3, 4.4, 4.5, 4.6, 4.8, 5.1 and 10
PIL sections updated – Heading, 2, 3, 4, 5 and 6
-
Changes: (Updated: 21 Oct 2022)
Single Variation
Variation Type: IB C.I.2.a
Variation Description:
To register an update to sections 4.3, 4.4, 4.5, 4.6, 4.8 and 5.1 of the SPC in line with the reference product (Tritace 5mg Tablets; PL 04425/0358). Consequentially, the leaflet has been updated.
Addition of ‘sodium-free’ statement in SPC section 4.4 and PIL.
Update to product descriptions in PIL section 6.
SmPC sections updated – 4.3, 4.4, 4.5, 4.6, 4.8, 5.1 and 10
PIL sections updated – Heading, 2, 3, 4, 5 and 6
-
Changes: (Updated: 21 Sep 2022)
Initial upload